 |
 |
KMT Hepatech and In Vitro ADMET Laboratories to Offer Human Hepatocytes from Chimeric Mouse
Edmonton, March 8, 2017 – KMT Hepatech, Inc. (“KMT”) and In Vitro ADMET Laboratories, LLC (“IVAL”) announced today that they have reached an agreement under which IVAL will prepare freshly isolated or cryopreserved (suspension or plateable grade) human hepatocytes derived from proprietary KMT mouse model - the KMT MouseTM (uPA/SCID mouse model with stable human hepatocytes engraftment of up to 95 per cent).